In this episode, Niall speaks to founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) and global leader in this research field, Rick Doblin. They discuss the benefits of using psychedelics wisely in clinical settings and how the growing dynamic research is showing that it could be a breakthrough therapy in treating a myriad of mental health issues including PTSD, treatment resistant depression, eating disorders and substance addiction. Learn more about your ad choices. Visit podcastchoices.com/adchoices